跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nasomate - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nasomate
Approved
STANDARD
Nasomate
Samchundang Pharm. Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9d8672dbcdbbd2c9
Company
Samchundang Pharm. Co., Ltd.
Type
Standard
Approval Details
Approval Id
9d8672dbcdbbd2c9
Drug Approval Philippines Name
Nasomate
Product Name
Nasomate
Registration Number
DR-XY45599
Brand Name
Nasomate
Generic Name
Mometasone furoate (as monohydrate)
Dosage Form
Nasal Spray Suspension
Dosage Strength
50 mcg/actuation
Manufacturer
Samchundang Pharm. Co., Ltd.
Importer
Optaderm Pharma Inc
Distributor
Optaderm Pharma Inc
Company Detail Path
/organization/samchundang-pharm-co-ltd
Issuance Date
21 September 2021
Expiry Date
20 September 2026
Pharmacologic Category
Corticosteroid
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9d8672dbcdbbd2c9
Type
Standard
Back to Philippines FDA Approvals